Koshinski Asset Management Inc. Buys 1,546 Shares of UnitedHealth Group Incorporated $UNH

Koshinski Asset Management Inc. raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 16.7% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 10,825 shares of the healthcare conglomerate’s stock after purchasing an additional 1,546 shares during the period. Koshinski Asset Management Inc.’s holdings in UnitedHealth Group were worth $3,377,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in UNH. Nuveen LLC bought a new position in shares of UnitedHealth Group in the 1st quarter worth about $3,846,764,000. Vanguard Group Inc. raised its position in shares of UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock worth $47,519,620,000 after acquiring an additional 5,583,343 shares in the last quarter. Wellington Management Group LLP raised its position in shares of UnitedHealth Group by 10.6% in the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock worth $13,537,859,000 after acquiring an additional 2,486,839 shares in the last quarter. National Bank of Canada FI raised its position in shares of UnitedHealth Group by 137.8% in the 1st quarter. National Bank of Canada FI now owns 1,641,177 shares of the healthcare conglomerate’s stock worth $859,518,000 after acquiring an additional 950,928 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. raised its position in shares of UnitedHealth Group by 13.6% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate’s stock worth $3,702,736,000 after acquiring an additional 847,054 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several analysts have recently commented on the company. Jefferies Financial Group raised their target price on UnitedHealth Group from $317.00 to $409.00 and gave the company a “buy” rating in a research note on Friday. Oppenheimer reduced their target price on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a research note on Wednesday, July 30th. Mizuho raised their target price on UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a research note on Thursday, October 9th. Cantor Fitzgerald restated an “overweight” rating and issued a $440.00 target price on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Finally, Zacks Research upgraded UnitedHealth Group from a “strong sell” rating to a “hold” rating in a research note on Monday, October 6th. Eighteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $385.13.

UnitedHealth Group Price Performance

UNH stock opened at $356.53 on Friday. The company has a market capitalization of $322.90 billion, a P/E ratio of 15.45, a price-to-earnings-growth ratio of 2.31 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The business has a 50-day simple moving average of $329.38 and a two-hundred day simple moving average of $344.86.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same quarter last year, the firm posted $6.80 EPS. UnitedHealth Group’s revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were paid a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s payout ratio is presently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.